Discounted Cash Flow Rating
Neutral
Return on Equity Rating
Strong Sell
Debt to Equity Rating
Neutral
Price to Earnings Rating
Strong Buy
Analyst Rating
Neutral
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Buy
Standard Deviation
Strong Buy
Williams %R
Strong Buy
Average Directional Index
Neutral
Insider Trading
Sell
Wall Street Data Solutions Rating
Neutral
B
Stoke Therapeutics, Inc. Common Stock (STOK)
Pharmaceutical Preparations
https://www.stoketherapeutics.com
Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. The company primarily operates in the U.S.
45 WIGGINS AVENUE
BEDFORD, MA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
06/19/2019
Market Cap
771,816,748
Shares Outstanding
44,650,000
Weighted SO
44,653,782
Total Employees
N/A
Upcoming Earnings
08/05/2024
Beta
0.8630
Last Div
0.0000
Range
3.35-17.58
Chg
0.4100
Avg Vol
690269
Mkt Cap
771816748
Exch
NASDAQ
Country
US
Phone
781 430 8200
DCF Diff
10.0391
DCF
4.3809
Div Yield
0.0000
P/S
50.9215
EV Multiple
-5.2576
P/FV
3.3683
Div Yield %
0.0000
P/E
-7.8936
PEG
-18.8656
Payout
0.0000
Current Ratio
6.6746
Quick Ratio
6.6746
Cash Ratio
4.3499
DSO
7.3448
DIO
0.0000
Op Cycle
7.3448
DPO
310.4625
CCC
-303.1177
Gross Margin
0.6940
Op Margin
-7.5565
Pretax Margin
-6.8331
Net Margin
-6.8331
Eff Tax Rate
-0.0820
ROA
-0.3365
ROE
-0.5789
ROCE
-0.4351
NI/EBT
1.0000
EBT/EBIT
0.9043
EBIT/Rev
-7.5565
Debt Ratio
0.0074
D/E
0.0094
LT Debt/Cap
0.0000
Total Debt/Cap
0.0093
Int Coverage
-10.0831
CF/Debt
-35.1137
Equity Multi
1.2680
Rec Turnover
49.6951
Pay Turnover
1.1757
Inv Turnover
0.0000
FA Turnover
1.4760
Asset Turnover
0.0492
OCF/Share
-1.4337
FCF/Share
-1.4458
Cash/Share
5.0579
OCF/Sales
-5.2751
FCF/OCF
1.0084
CF Coverage
-35.1137
ST Coverage
-35.1137
CapEx Coverage
-119.3343
Div&CapEx Cov
-119.3343
P/BV
3.3683
P/B
3.3683
P/S
50.9215
P/E
-7.8936
P/FCF
-9.5730
P/OCF
-10.2250
P/CF
-10.2250
PEG
-18.8656
P/S
50.9215
EV Multiple
-5.2576
P/FV
3.3683
DPS
0.0000
Latest Headlines (EST)
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
586.35K Shares Bought (13.01 %)
3.92M Shares Sold (86.99%)
3 - 6 Months
743.52K Shares Bought (80.47 %)
180.49K Shares Sold (19.53%)
6 - 9 Months
202.20K Shares Bought (18.04 %)
918.50K Shares Sold (81.96%)
9 - 12 Months
96.34K Shares Bought (86.53 %)
15.00K Shares Sold (13.47 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2018 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 3.27M | ▼ 2.80M | ▲ 4.22M |
Cost Of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.15M | ▲ 1.22M | ▼ 1.11M |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 2.12M | ▼ 1.59M | ▲ 3.10M |
Gross Profit Ratio | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 0.65 | ▼ 0.57 | ▲ 0.74 |
Research And Development Expenses | 3.00M | ▲ 7.09M | ▲ 8.90M | ▲ 15.80M | ▲ 21.06M | ▲ 21.15M | ▲ 21.81M |
General And Administrative Expenses | 1.54M | ▲ 3.98M | ▲ 5.68M | ▲ 8.72M | ▲ 9.38M | ▲ 10.61M | ▼ 10.22M |
Selling And Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -591.00K | ▲ -550.00K |
Selling General And Administrative Expenses | 1.54M | ▲ 3.98M | ▲ 5.68M | ▲ 8.72M | ▲ 9.38M | ▲ 10.02M | ▼ 9.67M |
Other Expenses | 0.00 | ▲ 4.00K | ▲ 15.00K | ▲ 42.00K | ▼ 41.00K | 41.00K | ▼ -428.00K |
Operating Expenses | 4.54M | ▲ 11.07M | ▲ 14.59M | ▲ 24.53M | ▲ 30.44M | ▲ 31.17M | ▲ 31.48M |
Cost And Expenses | 4.54M | ▲ 11.07M | ▲ 14.59M | ▲ 24.53M | ▲ 30.44M | ▲ 32.39M | ▲ 32.59M |
Interest Income | 270.00K | ▲ 904.00K | ▼ 10.00K | ▼ -18.00K | ▼ -544.00K | ▲ 2.59M | ▼ 0.00 |
Interest Expense | 0.00 | 0.00 | 0.00 | ▼ -78.00K | ▲ 1.48M | ▲ 2.59M | ▼ 2.43M |
Depreciation And Amortization | 75.00K | ▲ 139.00K | ▲ 237.00K | ▼ 235.00K | ▲ 609.00K | ▲ 1.22M | ▼ 1.11M |
Ebitda | -4.47M | ▼ -10.93M | ▼ -14.35M | ▼ -24.53M | ▼ -27.18M | ▼ -28.37M | ▲ -27.26M |
Ebitda Ratio | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -8.31 | ▼ -10.13 | ▲ -6.47 |
Operating Income | -4.54M | ▼ -11.07M | ▼ -14.59M | ▼ -24.53M | ▼ -27.18M | ▼ -29.59M | ▲ -28.37M |
Operating Income Ratio | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -8.31 | ▼ -10.56 | ▲ -6.73 |
Total Other Income Expenses Net | 260.00K | ▼ 4.00K | ▲ 15.00K | ▲ 42.00K | ▲ 1.52M | ▲ 2.63M | ▼ 2.00M |
Income Before Tax | -4.28M | ▼ -10.16M | ▼ -14.56M | ▼ -24.45M | ▼ -25.66M | ▼ -26.96M | ▲ -26.37M |
Income Before Tax Ratio | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -7.85 | ▼ -9.62 | ▲ -6.26 |
Income Tax Expense | 0.00 | ▼ -904.00K | ▲ -10.00K | ▼ -78.00K | ▼ -3.61M | ▲ 10.71M | ▼ 0.00 |
Net Income | -4.28M | ▼ -10.16M | ▼ -14.56M | ▼ -24.45M | ▲ -22.05M | ▼ -26.96M | ▲ -26.37M |
Net Income Ratio | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -6.74 | ▼ -9.62 | ▲ -6.26 |
Eps | -0.18 | ▼ -0.31 | ▼ -0.44 | ▼ -0.66 | ▲ -0.56 | ▼ -0.60 | ▲ -0.57 |
Eps Diluted | -0.18 | ▼ -0.31 | ▼ -0.44 | ▼ -0.66 | ▲ -0.56 | ▼ -0.60 | ▲ -0.57 |
Weighted Average Shs Out | 23.51M | ▲ 32.86M | ▲ 33.27M | ▲ 36.84M | ▲ 39.43M | ▲ 44.96M | ▲ 46.25M |
Weighted Average Shs Out Dil | 23.51M | ▲ 32.90M | ▲ 33.27M | ▲ 36.84M | ▲ 39.43M | ▲ 44.96M | ▲ 46.25M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2018 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | 105.40M | ▲ 222.47M | ▲ 287.31M | ▼ 144.90M | ▼ 113.56M | ▲ 191.44M | ▼ 178.58M |
Short Term Investments | 0.00 | 0.00 | 0.00 | ▲ 74.92M | ▲ 116.04M | ▼ 9.95M | ▼ 0.00 |
Cash And Short Term Investments | 105.40M | ▲ 222.47M | ▲ 287.31M | ▼ 219.81M | ▲ 229.60M | ▼ 201.39M | ▼ 178.58M |
Net Receivables | 196.00K | ▲ 281.00K | ▼ 6.00K | ▲ 132.00K | ▲ 588.00K | ▼ 64.00K | ▼ 11.00K |
Inventory | 0.00 | 0.00 | 0.00 | ▼ -132.00K | ▲ 10.93M | ▼ 0.00 | 0.00 |
Other Current Assets | 548.00K | ▲ 3.28M | ▲ 6.62M | ▲ 9.41M | ▼ 2.96M | ▲ 13.88M | ▲ 14.28M |
Total Current Assets | 106.14M | ▲ 226.03M | ▲ 293.93M | ▼ 229.22M | ▲ 244.07M | ▼ 215.34M | ▼ 192.87M |
Property Plant Equipment Net | 1.19M | ▲ 2.51M | ▲ 3.79M | ▲ 9.08M | ▲ 11.43M | ▲ 12.43M | ▼ 11.34M |
Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Goodwill And Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Long Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 569.00K | 569.00K | 569.00K |
Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Non Current Assets | 204.00K | ▲ 205.00K | 205.00K | ▲ 569.00K | ▼ 0.00 | 0.00 | ▲ 402.00K |
Total Non Current Assets | 1.40M | ▲ 2.72M | ▲ 4.00M | ▲ 9.65M | ▲ 12.00M | ▲ 13.00M | ▼ 12.31M |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.00 |
Total Assets | 107.54M | ▲ 228.75M | ▲ 297.93M | ▼ 238.87M | ▲ 256.07M | ▼ 228.34M | ▼ 205.18M |
Account Payables | 1.07M | ▼ 751.00K | ▲ 1.50M | ▲ 2.39M | ▼ 766.00K | ▲ 1.70M | ▲ 2.10M |
Short Term Debt | 0.00 | 0.00 | 0.00 | ▲ 1.51M | ▲ 2.36M | ▼ 2.06M | ▲ 2.21M |
Tax Payables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Revenue | 0.00 | 0.00 | 0.00 | ▲ 12.71M | ▲ 14.88M | ▲ 15.31M | ▲ 20.92M |
Other Current Liabilities | 1.40M | ▲ 3.35M | ▲ 9.93M | ▼ 540.00K | ▲ 13.39M | ▼ 11.75M | ▼ 10.36M |
Total Current Liabilities | 2.47M | ▲ 4.10M | ▲ 11.43M | ▲ 17.14M | ▲ 31.39M | ▼ 30.82M | ▲ 35.59M |
Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 2.72M | ▲ 4.77M | ▼ 4.13M |
Deferred Revenue Non Current | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 36.86M | ▼ 33.07M | ▼ 25.04M |
Deferred Tax Liabilities Non Current | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -2.72M | ▼ -4.77M | ▲ 0.00 |
Other Non Current Liabilities | 4.00K | ▲ 221.00K | ▲ 422.00K | ▲ 3.95M | ▼ 2.97M | ▲ 4.88M | ▼ 83.00K |
Total Non Current Liabilities | 4.00K | ▲ 221.00K | ▲ 422.00K | ▲ 3.95M | ▲ 39.82M | ▼ 37.96M | ▼ 29.25M |
Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Lease Obligations | 0.00 | 0.00 | 0.00 | ▲ 1.51M | ▲ 2.36M | ▲ 4.77M | ▼ 4.13M |
Total Liabilities | 2.47M | ▲ 4.32M | ▲ 11.85M | ▲ 21.09M | ▲ 71.22M | ▼ 68.78M | ▼ 64.84M |
Preferred Stock | 2.00K | ▼ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Common Stock | 0.00 | ▲ 3.00K | ▲ 4.00K | 4.00K | 4.00K | ▲ 5.00K | 5.00K |
Retained Earnings | -25.71M | ▼ -58.04M | ▼ -110.28M | ▼ -196.08M | ▼ -297.15M | ▼ -401.85M | ▼ -428.22M |
Accumulated Other Comprehensive Income Loss | -379.00K | ▼ -815.00K | ▲ 0.00 | ▼ -168.00K | ▼ -1.18M | ▲ -24.00K | ▲ 0.00 |
Other Total Stockholders Equity | 131.16M | ▲ 283.28M | ▲ 396.35M | ▲ 414.03M | ▲ 483.17M | ▲ 561.43M | ▲ 568.56M |
Total Stockholders Equity | 105.07M | ▲ 224.43M | ▲ 286.08M | ▼ 217.78M | ▼ 184.85M | ▼ 159.57M | ▼ 140.34M |
Total Equity | 105.07M | ▲ 224.43M | ▲ 286.08M | ▼ 217.78M | ▼ 184.85M | ▼ 159.57M | ▼ 140.34M |
Total Liabilities And Stockholders Equity | 107.54M | ▲ 228.75M | ▲ 297.93M | ▼ 238.87M | ▲ 256.07M | ▼ 228.34M | ▼ 205.18M |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities And Total Equity | 107.54M | ▲ 228.75M | ▲ 297.93M | ▼ 238.87M | ▲ 256.07M | ▼ 228.34M | ▼ 205.18M |
Total Investments | 0.00 | 0.00 | 0.00 | ▲ 74.92M | ▲ 116.04M | ▼ 10.52M | ▼ 569.00K |
Total Debt | 0.00 | 0.00 | 0.00 | ▲ 1.51M | ▲ 2.36M | ▲ 6.84M | ▼ 6.34M |
Net Debt | -105.40M | ▼ -222.47M | ▼ -287.31M | ▲ -143.39M | ▲ -111.20M | ▼ -184.61M | ▲ -172.24M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2018 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | -4.28M | ▼ -10.16M | ▼ -14.56M | ▼ -24.45M | ▼ -25.66M | ▼ -26.96M | ▲ -26.37M |
Depreciation And Amortization | 75.00K | ▲ 139.00K | ▲ 237.00K | ▼ 235.00K | ▲ 609.00K | ▲ 1.22M | ▼ 1.11M |
Deferred Income Tax | 0.00 | ▲ 1.11M | ▼ 0.00 | ▲ 57.00K | ▼ 0.00 | ▼ -9.64M | ▲ 0.00 |
Stock Based Compensation | 119.00K | ▲ 712.00K | ▲ 1.58M | ▲ 4.69M | ▲ 5.79M | ▲ 6.06M | ▼ 5.41M |
Change In Working Capital | 563.00K | ▼ -892.00K | ▲ 1.55M | ▲ 2.83M | ▼ -3.51M | ▲ -875.00K | ▼ -4.69M |
Accounts Receivables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payables | 0.00 | ▲ 891.00K | ▲ 5.20M | ▼ 2.90M | ▼ -633.00K | ▼ -1.15M | ▼ -1.92M |
Other Working Capital | 563.00K | ▼ -1.78M | ▼ -3.66M | ▲ -71.00K | ▼ -2.88M | ▲ 274.00K | ▼ -2.77M |
Other Non Cash Items | 10.00K | ▼ -1.11M | ▲ 266.00K | ▲ 386.00K | ▲ 392.00K | ▲ 9.55M | ▼ 9.53M |
Net Cash Provided By Operating Activities | -3.52M | ▼ -10.20M | ▼ -10.93M | ▼ -16.26M | ▼ -22.37M | ▲ -20.65M | ▼ -24.57M |
Investments In Property Plant And Equipment | -93.00K | ▼ -568.00K | ▲ -90.00K | ▼ -203.00K | ▼ -409.00K | ▲ -229.00K | ▲ -12.00K |
Acquisitions Net | 0.00 | 0.00 | 0.00 | ▲ 70.44M | ▼ -45.34M | ▲ 0.00 | 0.00 |
Purchases Of Investments | 0.00 | 0.00 | 0.00 | ▼ -82.24M | ▲ 4.87M | ▼ 0.00 | 0.00 |
Sales Maturities Of Investments | 0.00 | 0.00 | 0.00 | ▲ 12.00M | ▲ 18.03M | ▼ 15.00M | ▼ 10.00M |
Other Investing Activities | 10.00K | ▼ -1.00K | ▲ 0.00 | ▲ 11.80M | ▲ 45.34M | ▼ 15.00M | ▼ 10.00M |
Net Cash Used For Investing Activities | -83.00K | ▼ -569.00K | ▲ -90.00K | ▲ 11.80M | ▲ 22.49M | ▼ 14.77M | ▼ 9.99M |
Debt Repayment | 0.00 | 0.00 | ▼ -1.00K | ▲ 0.00 | 0.00 | 0.00 | 0.00 |
Common Stock Issued | 0.00 | 0.00 | ▲ 105.40M | ▼ 777.00K | ▼ 42.00K | ▲ 7.34M | ▼ 1.72M |
Common Stock Repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 89.78M | ▼ 192.00K | ▲ 1.47M | ▼ -606.00K | ▲ 43.00K | ▲ 7.34M | ▼ 1.72M |
Net Cash Used Provided By Financing Activities | 89.78M | ▼ 192.00K | ▲ 106.87M | ▼ 171.00K | ▼ 43.00K | ▲ 7.34M | ▼ 1.72M |
Effect Of Forex Changes On Cash | -1.00K | ▲ 0.00 | 0.00 | ▲ 16.26M | ▼ 0.00 | 0.00 | 0.00 |
Net Change In Cash | 86.18M | ▼ -10.58M | ▲ 95.85M | ▼ -4.29M | ▲ 160.00K | ▲ 1.47M | ▼ -12.86M |
Cash At End Of Period | 105.60M | ▲ 222.68M | ▲ 287.51M | ▼ 145.46M | ▼ 114.13M | ▲ 191.44M | ▼ 178.58M |
Cash At Beginning Of Period | 19.42M | ▲ 233.25M | ▼ 191.67M | ▼ 149.75M | ▼ 113.97M | ▲ 189.98M | ▲ 191.44M |
Operating Cash Flow | -3.52M | ▼ -10.20M | ▼ -10.93M | ▼ -16.26M | ▼ -22.37M | ▲ -20.65M | ▼ -24.57M |
Capital Expenditure | -93.00K | ▼ -568.00K | ▲ -90.00K | ▼ -203.00K | ▼ -409.00K | ▲ -229.00K | ▲ -12.00K |
Free Cash Flow | -3.61M | ▼ -10.77M | ▼ -11.02M | ▼ -16.46M | ▼ -22.78M | ▲ -20.88M | ▼ -24.58M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Generating AI Summary...
(This could take up to 5 minutes)